Stay up-to-date with the latest happenings in the rapidly evolving field of In Vitro Diagnostics (IVD) in China.

Microfluidic chip technology integrates basic operational units such as sample preparation, reaction, analysis, and detection, harnessing techniques from the fields of chemistry and biology into a chip of several square centimeters, automatically completing the entire analysis process.

Cancer Genetics today reported a 15 percent increase in second quarter revenues on improved performance by its core discovery services operations.

Aqualung Therapeutics said on Tuesday that it has been awarded a $225,000 grant from the National Institutes of Health to develop a panel of biomarkers, called CRIT-ICU, for stratifying patients at risk for acute respiratory distress syndrom

10x Genomics is looking to raise up to $100 million in an initial public offering, according to documents filed Monday with the US Securities and Exchange Commission.

Agilent Technologies reported after the close of the market on Wednesday that its third quarter revenues rose 6 percent year over year, thanks largely to an 11 percent increase in revenues for its diagnostics and genomics business.

Brigham and Women's Hospital announced recently that it has opened the Preventive Genomics Clinic, an academically affiliated clinical service to provide comprehensive DNA sequencing, interpretation, and reporting of disease-associated genes

Genomind and NeuroFlow recently announced an agreement that combines NeuroFlow's digital health platform with Genomind's genetic testing service with the aim of improving patient wellness and reducing costs across a continuum of care for con

IncellDx and Kindstar Global announced recently that they have signed master collaboration and exclusive distribution agreements for three of IncellDx's single-cell immuno-oncology and oncology diagnostic products for China.

GenMark Diagnostics reported after the close of the market on Monday a 23 percent increase in second quarter revenues, driven by strong placements of its ePlex analyzer.

SpeeDx announced recentlythat it has raised a total of $15 million from a US investment group.The Sydney, Australia-based molecular diagnostics developer said it had raised up to $10 million in additional equity investment from US-based Nort

The FDA has cleared Drawbridge Health’s blood collection device designed to help monitor long-term blood sugar levels in people with diabetes, which the company describes as easier and less painful than a hypodermic needle.